Product

Adipose-derived regenerative cells

1 clinical trial

1 indication

Clinical trial
Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous
Status: Not yet recruiting, Estimated PCD: 2026-09-01